Sven Becker, Marie-Madelaine Dolmans, Francisco Carmona Herrera, Felice Petraglia, Stefan P. Renner, Raluca Ionescu-Ittu, Julien St-Pierre, Mitra Boolell, Elke Bestel, Satoshi Hori, Jacques Donnez
{"title":"林扎戈利治疗的子宫肌瘤患者疼痛减轻：PRIMROSE 1期和2期3期试验的二次中介分析","authors":"Sven Becker, Marie-Madelaine Dolmans, Francisco Carmona Herrera, Felice Petraglia, Stefan P. Renner, Raluca Ionescu-Ittu, Julien St-Pierre, Mitra Boolell, Elke Bestel, Satoshi Hori, Jacques Donnez","doi":"10.1111/1471-0528.18190","DOIUrl":null,"url":null,"abstract":"Among women with uterine fibroids (UFs), we assess the extent to which the linzagolix effect on pain alleviation is explained by its effect on reducing heavy menstrual bleeding (HMB) and fibroid volume (FV).","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"95 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials\",\"authors\":\"Sven Becker, Marie-Madelaine Dolmans, Francisco Carmona Herrera, Felice Petraglia, Stefan P. Renner, Raluca Ionescu-Ittu, Julien St-Pierre, Mitra Boolell, Elke Bestel, Satoshi Hori, Jacques Donnez\",\"doi\":\"10.1111/1471-0528.18190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Among women with uterine fibroids (UFs), we assess the extent to which the linzagolix effect on pain alleviation is explained by its effect on reducing heavy menstrual bleeding (HMB) and fibroid volume (FV).\",\"PeriodicalId\":8984,\"journal\":{\"name\":\"BJOG: An International Journal of Obstetrics & Gynaecology\",\"volume\":\"95 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BJOG: An International Journal of Obstetrics & Gynaecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/1471-0528.18190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJOG: An International Journal of Obstetrics & Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/1471-0528.18190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials
Among women with uterine fibroids (UFs), we assess the extent to which the linzagolix effect on pain alleviation is explained by its effect on reducing heavy menstrual bleeding (HMB) and fibroid volume (FV).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
